Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately
The FDA has categorized this as a Class I recall. If patients update their phone or watch apps as needed, they can continue to use these devices like normal.
Cardiologist sues hospital after he was allegedly let go for sharing safety concerns
The veteran interventional cardiologist claims he was pushed out after repeatedly asking for more coverage from cardiothoracic surgeons in addition to other improvements. The hospital, meanwhile, described the lawsuit as a “collection of false allegations."
Why all heart patients should be vaccinated against the flu, COVID-19, RSV
The American College of Cardiology has shared new recommendations highlighting the protective benefits of a variety of vaccines. The new guidance also examines how to speak with patients who are hesitant to be vaccinated.
Heart surgeons see more potential in AI than colleagues from other fields
Cardiac surgeons see significant value in AI's ability to assist clinicians with administrative tasks and patient selection. When it comes to making clinical decisions, however, there is still a certain amount of skepticism.
New Apple Watch Ultra 3 makes early hypertension detection a priority
"This tool empowers patients and clinicians to work together, putting prevention at the center of care," said Ami B. Bhatt, MD, ACC chief innovation officer. "What we really want to do is create patient agency and reach as many people as we can for earlier detection of high blood pressure."

Raj Makkar, MD, director, interventional cardiology, director, Interventional Cardiology Research Program and professor of medicine, Smidt Heart Institute, Cedars-Sinai Hospital, presented the late-breaking Align-AR clinical trial at ACC 2025 on the first 500 patients treated for aortic regurgitation using the Jena Valve transcatheter aortic valve replacement (TAVR) device.

First 500 patients in Align-AR trial using TAVR for pure aortic regurgitation show strong outcomes

Raj Makkar, MD, Cedars-Sinai, explains the late-breaking data from the Align-AR trial on the first 500 patients treated for aortic regurgitation using the Jena Valve TAVR device.

How often does mid-treatment imaging change how cancers are managed?

Imaging might not drive as many treatment adjustments as previously believed, according to a new meta-analysis.

The Agitation Solutions Orbis Microbubble Generator simplifies and streamlines the process of saline agitation and delivery for cardiac bubble studies using a single use syringe. It is was cleared for use in Canada in 2024.

Right heart cardiac ultrasound contrast agent for shunts enters U.S. trial

Currently there are no FDA cleared echocardiography contrast agents commercially available for use on the right side of the heart to detect shunts, but a new agent that promises to improve workflow and imaging is about to enter a U.S. trial.

American College of Cardiology (ACC) President Christopher Kramer, MD, FACC, spoke at a hearing of the U.S. House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies March 9 to urge lawmakers to allocate full funding for the Cardiomyopathy Health Education, Awareness, Research, and Training in Schools (HEARTS) Act (H.R.6829). It was signed into law in the closing weeks of the Biden administration. #ACC

ACC testifies in Washington to get funding for the HEARTS Act amid big cuts to healthcare

ACC President Christopher Kramer, MD, testified before a Congressional subcommittee to ask for federal funding to support a new law aimed at reducing sudden cardiac arrest deaths, and to support NIH research.

OSU researchers studying ability of silver nanoparticles to enhance medical imaging

Why researchers believe silver nanoparticles could 'revolutionize' medical imaging

Researchers at Oregon State University are working on developing a way to make contrast agents more targeted.

Michael Reardon, MD, explained the low-risk Evolut 5-year results of TAVR vs. SAVR at ACC 2025. #ACC #ACC25 #ACC2025

5-year Evolut Low Risk Data: Durable clinical outcomes, outstanding valve performance

Clinical

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately

Cardiologist sues hospital after he was allegedly let go for sharing safety concerns

Why all heart patients should be vaccinated against the flu, COVID-19, RSV

Heart surgeons see more potential in AI than colleagues from other fields

New Apple Watch Ultra 3 makes early hypertension detection a priority